A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta.
Hashimoto. Y Y; Niikura. T T; Tajima. H H; Yasukawa. T T; Sudo. H H; Ito. Y Y; Kita. Y Y; Kawasumi. M M; Kouyama. K K; Doyu. M M; Sobue. G G; Koide. T T; Tsuji. S S; Lang. J J; Kurokawa. K K; Nishimoto. I I
Key Findings
- Humanin peptide blocks neuron death caused by multiple familial Alzheimer’s disease genes and amyloid‑beta
- The protective effect requires the exact amino‑acid sequence of Humanin
- Humanin is secreted by cells, suggesting it can act extracellularly
Practical Outcomes
- At this stage it’s a basic research finding, not a ready‑to‑use supplement or protocol. It signals that Humanin or similar molecules might become neuroprotective agents in the future, but more animal and human studies are needed before any dosage or DIY use can be recommended.
Summary
Scientists found that a tiny protein called Humanin can stop brain cells from dying when they’re exposed to Alzheimer‑related genes or amyloid‑beta, but it doesn’t help with other types of cell stress. The protein works only when its exact sequence is unchanged and is released into the surrounding fluid, hinting it could be a clue for new Alzheimer’s treatments.
Abstract
Through functional expression screening, we identified a gene, designated Humanin (HN) cDNA, which encodes a short polypeptide and abolishes death of neuronal cells caused by multiple different types of familial Alzheimer's disease genes and by Abeta amyloid, without effect on death by Q79 or superoxide dismutase-1 mutants. Transfected HN cDNA was transcribed to the corresponding polypeptide and then was secreted into the cultured medium. The rescue action clearly depended on the primary structure of HN. This polypeptide would serve as a molecular clue for the development of new therapeutics for Alzheimer's disease targeting neuroprotection.
Study Information
pubmed
2001
2001-05-22T00:00:00.000Z
10.1073/pnas.101133498
590
29